What stage does BioScience Ventures Group AG invest at?

BioScience Ventures Group AG invests at the Pre-Seed, Seed, Series A stages.

What is BioScience Ventures Group AG's typical check size?

BioScience Ventures Group AG typically writes checks of $220K – $550K.

What sectors does BioScience Ventures Group AG focus on?

BioScience Ventures Group AG focuses on Biotech, Healthtech, Medical Devices.

Where is BioScience Ventures Group AG located?

BioScience Ventures Group AG is headquartered in Munich, DE.

BioScience Ventures Group AG

Angel network

Munich · Pre-Seed–Series A · 2 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

BSVG is a network of business angels focused solely on early-stage life-science investments, writing rounds of roughly EUR 0.2 to 0.5 million each. Beyond capital, the group brings a team with medical and pharmacological backgrounds specialized in drug development and the design of preclinical and clinical studies, particularly in the field of biologics such as antibodies and proteins. This domain expertise, combined with long experience in the investment business, is used to improve the efficiency of investments and reduce development costs for portfolio companies.

Invests inBiotech Healthtech Medical Devices Austria Germany Munich Switzerland

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

Check

$220K – $550K

Munich, DE

Instruments

Equity

Founded

2001

Tracked investments

Team · 2 people

from the firm's website & public directories

Nicole Wistuba· Managing Director

Managing Director of BSVG who joined in 2001 after completing a PhD in biology at the University of Würzburg. She oversees the company's operational business and sits on the boards of ugichem GmbH, MagnaMedics GmbH and APEPTICO.

n•••@bsvg.comreveal

Markus Heiss· Prof. Dr.

A surgeon specializing in visceral and vascular surgery, he serves as Medical Director of the Department of Visceral, Vascular and Transplant Surgery at Medical Center Cologne-Merheim and holds a surgery faculty chair at the University of Witten/Herdecke. His specialties include surgical oncology, tumor immunology, minimally invasive surgery and transplant surgery.

Investments · 3 tracked

founders shown can be your intro path

APEPTICOapeptico.com

PartnerNicole Wistuba· solo GP

MagnaMedicsmagnamedics.com

PartnerNicole Wistuba· solo GP

Nano4Imagingnano4imaging.com

Develops and produces contrast agents and devices for in-vivo MRI imaging of implants, transplants and minimally invasive devices such as catheters and guidewires.

PartnerNicole Wistuba· solo GP

Frequently asked questions

What stage does BioScience Ventures Group AG invest at?: BioScience Ventures Group AG invests at the Pre-Seed, Seed, Series A stages.
What is BioScience Ventures Group AG's typical check size?: BioScience Ventures Group AG typically writes checks of $220K – $550K.
What sectors does BioScience Ventures Group AG focus on?: BioScience Ventures Group AG focuses on Biotech, Healthtech, Medical Devices.
Where is BioScience Ventures Group AG located?: BioScience Ventures Group AG is headquartered in Munich, DE.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Excell Partners

Excell Partners manages a state-supported fund in partnership with the University of Rochester and New York State, offering pre-seed and seed stage capital to early-stage technology companies in Upstate New York.